Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer

Edward L. Gheiler, Marcos V. Tefilli, Rabi Tiguert, David Grignon, Michael L. Cher, Wael Sakr, J. Edson Pontes, David P. Wood

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Objectives. To determine preradiation and preoperative clinical staging and postoperative pathologic factors that can predict disease-free survival in patients undergoing salvage surgery for radio-recurrent prostate cancer. Methods. A retrospective review was performed on 40 patients who underwent salvage surgery for radio-recurrent prostate cancer. Preradiation and preoperative clinical staging factors, as well as pathologic stage were analyzed as predictors of disease-free survival. Biochemical failure was defined as a persistent serum prostate-specific antigen (PSA) elevation greater than 0.4 ng/mL. Results. As a group, salvage surgery provided excellent clinical disease control in 35 of 40 patients (87.5%). Overall, 18 of 38 (47.4%) patients analyzed had no evidence of biochemical progression. Preradiation clinical stage and pathologically organ-confined disease were statistically significant predictors of disease-free survival (P = 0.03 and P = 0.02, respectively). Seminal vesicle invasion and positive lymph nodes were the worst pathologic prognostic factors. Preoperative clinical T1c disease approached statistical significance in predicting pathologically organ- confined disease and disease-free survival (P = 0.08 and P = 0.07, respectively). Conclusions. Ideal candidates for salvage surgery should have preradiation and preoperative clinically organ-confined disease. All patients with pathologically organ-confined disease following salvage prostatectomy were disease free at a mean follow-up of 36.1 months. Salvage surgery, although technically feasible, should not be widely advocated as an effective curative treatment in patients with locally advanced disease at the time of diagnosis.

Original languageEnglish (US)
Pages (from-to)789-795
Number of pages7
JournalUrology
Volume51
Issue number5
DOIs
StatePublished - May 1998
Externally publishedYes

Fingerprint

Radio
Prostatic Neoplasms
Disease-Free Survival
Seminal Vesicles
Prostate-Specific Antigen
Prostatectomy
Lymph Nodes
Serum

ASJC Scopus subject areas

  • Urology

Cite this

Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. / Gheiler, Edward L.; Tefilli, Marcos V.; Tiguert, Rabi; Grignon, David; Cher, Michael L.; Sakr, Wael; Pontes, J. Edson; Wood, David P.

In: Urology, Vol. 51, No. 5, 05.1998, p. 789-795.

Research output: Contribution to journalArticle

Gheiler, EL, Tefilli, MV, Tiguert, R, Grignon, D, Cher, ML, Sakr, W, Pontes, JE & Wood, DP 1998, 'Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer', Urology, vol. 51, no. 5, pp. 789-795. https://doi.org/10.1016/S0090-4295(98)00096-X
Gheiler, Edward L. ; Tefilli, Marcos V. ; Tiguert, Rabi ; Grignon, David ; Cher, Michael L. ; Sakr, Wael ; Pontes, J. Edson ; Wood, David P. / Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. In: Urology. 1998 ; Vol. 51, No. 5. pp. 789-795.
@article{6e8e202b2d984444b64aee43a8bf8e23,
title = "Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer",
abstract = "Objectives. To determine preradiation and preoperative clinical staging and postoperative pathologic factors that can predict disease-free survival in patients undergoing salvage surgery for radio-recurrent prostate cancer. Methods. A retrospective review was performed on 40 patients who underwent salvage surgery for radio-recurrent prostate cancer. Preradiation and preoperative clinical staging factors, as well as pathologic stage were analyzed as predictors of disease-free survival. Biochemical failure was defined as a persistent serum prostate-specific antigen (PSA) elevation greater than 0.4 ng/mL. Results. As a group, salvage surgery provided excellent clinical disease control in 35 of 40 patients (87.5{\%}). Overall, 18 of 38 (47.4{\%}) patients analyzed had no evidence of biochemical progression. Preradiation clinical stage and pathologically organ-confined disease were statistically significant predictors of disease-free survival (P = 0.03 and P = 0.02, respectively). Seminal vesicle invasion and positive lymph nodes were the worst pathologic prognostic factors. Preoperative clinical T1c disease approached statistical significance in predicting pathologically organ- confined disease and disease-free survival (P = 0.08 and P = 0.07, respectively). Conclusions. Ideal candidates for salvage surgery should have preradiation and preoperative clinically organ-confined disease. All patients with pathologically organ-confined disease following salvage prostatectomy were disease free at a mean follow-up of 36.1 months. Salvage surgery, although technically feasible, should not be widely advocated as an effective curative treatment in patients with locally advanced disease at the time of diagnosis.",
author = "Gheiler, {Edward L.} and Tefilli, {Marcos V.} and Rabi Tiguert and David Grignon and Cher, {Michael L.} and Wael Sakr and Pontes, {J. Edson} and Wood, {David P.}",
year = "1998",
month = "5",
doi = "10.1016/S0090-4295(98)00096-X",
language = "English (US)",
volume = "51",
pages = "789--795",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer

AU - Gheiler, Edward L.

AU - Tefilli, Marcos V.

AU - Tiguert, Rabi

AU - Grignon, David

AU - Cher, Michael L.

AU - Sakr, Wael

AU - Pontes, J. Edson

AU - Wood, David P.

PY - 1998/5

Y1 - 1998/5

N2 - Objectives. To determine preradiation and preoperative clinical staging and postoperative pathologic factors that can predict disease-free survival in patients undergoing salvage surgery for radio-recurrent prostate cancer. Methods. A retrospective review was performed on 40 patients who underwent salvage surgery for radio-recurrent prostate cancer. Preradiation and preoperative clinical staging factors, as well as pathologic stage were analyzed as predictors of disease-free survival. Biochemical failure was defined as a persistent serum prostate-specific antigen (PSA) elevation greater than 0.4 ng/mL. Results. As a group, salvage surgery provided excellent clinical disease control in 35 of 40 patients (87.5%). Overall, 18 of 38 (47.4%) patients analyzed had no evidence of biochemical progression. Preradiation clinical stage and pathologically organ-confined disease were statistically significant predictors of disease-free survival (P = 0.03 and P = 0.02, respectively). Seminal vesicle invasion and positive lymph nodes were the worst pathologic prognostic factors. Preoperative clinical T1c disease approached statistical significance in predicting pathologically organ- confined disease and disease-free survival (P = 0.08 and P = 0.07, respectively). Conclusions. Ideal candidates for salvage surgery should have preradiation and preoperative clinically organ-confined disease. All patients with pathologically organ-confined disease following salvage prostatectomy were disease free at a mean follow-up of 36.1 months. Salvage surgery, although technically feasible, should not be widely advocated as an effective curative treatment in patients with locally advanced disease at the time of diagnosis.

AB - Objectives. To determine preradiation and preoperative clinical staging and postoperative pathologic factors that can predict disease-free survival in patients undergoing salvage surgery for radio-recurrent prostate cancer. Methods. A retrospective review was performed on 40 patients who underwent salvage surgery for radio-recurrent prostate cancer. Preradiation and preoperative clinical staging factors, as well as pathologic stage were analyzed as predictors of disease-free survival. Biochemical failure was defined as a persistent serum prostate-specific antigen (PSA) elevation greater than 0.4 ng/mL. Results. As a group, salvage surgery provided excellent clinical disease control in 35 of 40 patients (87.5%). Overall, 18 of 38 (47.4%) patients analyzed had no evidence of biochemical progression. Preradiation clinical stage and pathologically organ-confined disease were statistically significant predictors of disease-free survival (P = 0.03 and P = 0.02, respectively). Seminal vesicle invasion and positive lymph nodes were the worst pathologic prognostic factors. Preoperative clinical T1c disease approached statistical significance in predicting pathologically organ- confined disease and disease-free survival (P = 0.08 and P = 0.07, respectively). Conclusions. Ideal candidates for salvage surgery should have preradiation and preoperative clinically organ-confined disease. All patients with pathologically organ-confined disease following salvage prostatectomy were disease free at a mean follow-up of 36.1 months. Salvage surgery, although technically feasible, should not be widely advocated as an effective curative treatment in patients with locally advanced disease at the time of diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=0031745356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031745356&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(98)00096-X

DO - 10.1016/S0090-4295(98)00096-X

M3 - Article

C2 - 9610593

AN - SCOPUS:0031745356

VL - 51

SP - 789

EP - 795

JO - Urology

JF - Urology

SN - 0090-4295

IS - 5

ER -